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Fig 3. The suture ends are then passed through a similar
Teflon patch on the right ventricular side of the septum.
Fig 4. The suture length is tied firmly, thereby sandwiching
the septum between the 2 stiff Teflon patches.
5. The conduction bundle does not come near the muscular
VSDs.
Placing a left-sided patch without opening the left ventri-
cle, with its attendant risks, would thus seem the best way to
tackle the problem of multiple muscular VSDs. It is here that
our simple method scores over other more elaborate proce-
dures. We abandoned the authors' method of placing multiple
sutures in the oversized patch, because the procedure is cum-
bersome and tedious, as high-lighted by Dr John Brown2 in
the discussion following the article. Instead, we find that
passing the 2 ends of a 4-0 Prolene suture through the VSD is
a neat and simple method, taking just 5 to 6 minutes to close
a VSD. It can be repeated for the other VSDs without a great
increase in cardiopulmonary bypass time, and we have creat-
ed a maximum of 3 such sandwiches in a patient with a sub-
sequent classic closure of the perimembranous VSD. On fol-
low-up echocardiography, none of the patients operated on
with this technique had residual shunts, which encourages us
to continue using our simple technique.
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Reply to the Editor:
My colleagues and I appreciate the thoughtful comments
by Kapoor and associates on our recent article concerning the
techniques used for the closure of multiple muscular ventric-
ular septal defects (VSDs). They have underscored some of
the difficulties encountered in the exposure of muscular
defects and describe a variation on one of the techniques that
we included in our report. As these authors point out, and as
emphasized in our manuscript, muscular VSDs will appear as
multiple openings when viewed from the right side, but are
often a single defect as seen from the left. Therefore, an over-
sized patch can be an effective means to close the defects
when placed on the left ventricular surface. Because the pres-
sure in the left ventricle will be higher than that in the right
after repair, only a few sutures are required to anchor the
patch in position. Although the authors' technique uses an
outlet VSD to gain access to the left ventricular side, the basic
principle described in our report is the same. Additionally,
some patients will not have an additional outlet VSD of suf-
ficient size to permit access to the left side of the septum.
Kapoor and associates note that the approach described in our
article may be "cumbersome," but we have not found that to
be the case. As noted, the relatively few sutures required to
hold the patch in place make the technique straightforward.
Furthermore, in our experience only a single patch has been
necessary to effectively close all the defects in the anterior
and midmuscular septum, in contrast to the need for up to 3
patches in the patients described by Kapoor and his associ-
ates. Possibly, the more direct approach through the anterior
muscular septum used in our patients permits more accurate
placement of the patch over the center of the VSDs such that
only a single patch is required.
Although the surgical management of multiple muscular
VSDs remains a challenge, it is clear that secure and com-
plete closure can be achieved in most patients using the tech-
niques described in our report, as well as those illustrated in
the letter by Kapoor and colleagues. Early repair in infancy,
before secondary muscle hypertrophy makes exposure even
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Histologic grading: A, B, C or 1, 2, 3?
To the Editor:
Mr Lee and colleagues from Dr Shennib's group are to be
congratulated for an interesting and provocative study (J
Thorac Cardiovasc Surg 1998;115:822-7) that supports their
hypothesis that bronchiolitis obliterans is not related just to
chronic rejection in lung allografts. Using activated charcoal
as an airway irritant, the authors demonstrated that either an
irritant alone or reduced immunosuppression after transplan-
tation resulted in mild bronchiolitis, but the combination of
airway irritant and reduced immunosuppression produced
more impressive histologic findings consistent with oblitera-
tive bronchiolitis.
However, I take issue with the calculation of mean grades
of airway injury using a grading system that arbitrarily
assigns numbers to histologic patterns of injury. If the histo-
logic categories were labeled A, B, C, and D instead of 1, 2,
3, and 4, what would be the mean of 2 A's and 3 C's? It would
be statistically appropriate to compare the groups by looking
at the distribution of scores within each group, rather than
calculating a mean from data that are not arithmetic.
Although this is common practice with histologic grades, it is
mathematically inappropriate. Unfortunately, the need for
nonparametric analysis translates into a requirement for a
much larger number of animals to establish statistical signif-
icance to the observation. This criticism is not meant to
detract from the elegance of the experiment but only to raise
the point that not all observations need to be "statistically sig-
nificant" before they are relevant. Perhaps the authors could
share the distribution of scores, rather than the mean scores.
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Reply to the Editor:
The comment made by Dr Thomas Egan is well taken.
Grading the severity of airway injury by nonparametric
analysis requires an extensive number of animals, which we
could not determine before the experiment. When data were
reviewed by classification A, B, C, and D instead of 1, 2, 3,
and 4, we found there were 5 A's and 3 B's in group I (trans-
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plantation alone), 4 C's and 6 D's in group II (transplantation
plus charcoal), and 2 A's, 7 B's, and 1 C in group III (char-
coal alone). As such, the data stand to confirm that the com-
bination of transplantation and charcoal transtracheal injec-
tion result in more pronounced injury to the airway.
Hani Shennib, MD
Associate Professor
Department of Cardiothoracic Surgery
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Multiple primary lung carcinomas
To the Editor:
The report by Okada and colleagues! highlights the treat-
ment options and survival statistics that are appropriate for
patients with multiple primary lung carcinomas (MPLCs),
but we think some further points need to be discussed.
In a recent article by Antakli and colleagues,2 a set of cri-
teria modified from Martini and Melamed3 has been applied
to differentiate MPLCs and recurrence of satellite nodules. In
addition to those mentioned by Okada and associates, associ-
ated premalignant lesions and different DNA ploidy have
been presented as the 2 other criteria in the case of identical
histologic type.2 When Martini and Melamed's criteria were
not conclusive, they advocated DNA ploidy to provide a def-
inite answer to this dilemma. However, Okada and colleagues
have not suggested using the ploidy issue for patients with
MPLCs.
We performed left pneumonectomy for a 60-year-old man
who was operated on for squamous cell carcinoma of the lung
(T2 Nl MO, grade III). One year after the operation, a nodule
with a 2.5-cm diameter located in the right upper lobe was
detected by both chest roentgenography and chest computed
tomography. Segmentectomy was performed, and the histo-
logic type of this tumor was the same as that of the first one
(T2 NO MO, grade III). We considered this tumor to be a sec-
ond primary lung cancer, because the tumor was anatomical-
ly separate and did not have any systemic metastases or medi-
astinal spread. On the other hand, although the number of
criteria that had to be met in the case of identical histologic
type was sufficient, we used the ploidy issue in our patient.
Even though the histologic features were the same in all of
the lesions, the DNA ploidy signatures differed.
Although lung-saving procedures for a primary lesion are
advocated in the article, 1 the risk of having MPLCs after
pneumonectomy is significantly lower than after lobectomies
or miniresections.2
Another point is the striking prevalence of smoking among
the patients with MPLCs and the preventive effect of cessa-
tion that has been demonstrated by many authors.2,4 Do
Okada and associates have any information about the preva-
lence of smoking among their patients?
From the historical point of view, we would like to know
